"Regional Obstetrical Consultants (ROC) is a group of high-risk obstetricians and other healthcare professionals who provide state-of-the-art care for women with risk factors that may affect their pregnancy. ROC's experienced team includes maternal-fetal specialists (perinatologists), sonographers, nurses, genetic counselors and diabetic educators."

During the past decade, Regional Obstetrical Consultants conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Obstetrical Consultants" #1 sponsor was "Progenity, Inc." with 3 trials, followed by "Hologic, Inc." with 2 trials sponsored, "Regional Obstetrical Consultants" with 2 trials sponsored, "Sera Prognostics, Inc." with 2 trials sponsored and "AMAG Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Obstetrical Consultants" #1 collaborator was "Obstetrix Medical Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Regional Obstetrical Consultants" are "Down Syndrome" (3 trials), "Edwards Syndrome" (3 trials), "DiGeorge Syndrome" (2 trials), "Klinefelter Syndrome" (2 trials) and "Patau Syndrome" (2 trials). Many other conditions were trialed in "Regional Obstetrical Consultants" in a lesser frequency.

Most popular intervention types in "Regional Obstetrical Consultants" are "Other" (4 trials), "Drug" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "8% progesterone vaginal gel" (1 trials), "AMAG-423 (digoxin immune fab)" (1 trials), "Blood sampling for Laboratory Developed Test (LDT) analysis" (1 trials), "Insulin versus glucovance (glyburide/metformin)" (1 trials) and "Magnesium sulfate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Obstetrical Consultants" are 11 trials for "Female" genders.

Currently, there are NaN active trials in "Regional Obstetrical Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Regional Obstetrical Consultants, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Obstetrical Consultants, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".